These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9460995)

  • 1. Stochastic modelling of tumorigenesis in p53 deficient mice.
    Mao JH; Lindsay KA; Balmain A; Wheldon TE
    Br J Cancer; 1998; 77(2):243-52. PubMed ID: 9460995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
    Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA
    Nat Genet; 1995 Mar; 9(3):305-11. PubMed ID: 7773294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Donehower LA; Harvey M; Slagle BL; McArthur MJ; Montgomery CA; Butel JS; Bradley A
    Nature; 1992 Mar; 356(6366):215-21. PubMed ID: 1552940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis.
    Kemp CJ; Wheldon T; Balmain A
    Nat Genet; 1994 Sep; 8(1):66-9. PubMed ID: 7987394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tissue-specific growth patterns of target stem cells on the spectrum of tumours resulting from multistage tumorigenesis.
    Mao JH; Lindsay KA; Mairs RJ; Wheldon TE
    J Theor Biol; 2001 May; 210(1):93-100. PubMed ID: 11343433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
    Harvey M; McArthur MJ; Montgomery CA; Butel JS; Bradley A; Donehower LA
    Nat Genet; 1993 Nov; 5(3):225-9. PubMed ID: 8275085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
    Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15608-12. PubMed ID: 9861017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
    Jones SN; Sands AT; Hancock AR; Vogel H; Donehower LA; Linke SP; Wahl GM; Bradley A
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14106-11. PubMed ID: 8943068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
    Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
    Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stochastic model for multistage tumorigenesis in developing and adult mice.
    Mao JH; Wheldon TE
    Math Biosci; 1995 Oct; 129(2):95-110. PubMed ID: 7549221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.
    Conde C; Mark M; Oliver FJ; Huber A; de Murcia G; Ménissier-de Murcia J
    EMBO J; 2001 Jul; 20(13):3535-43. PubMed ID: 11432840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy.
    Tommasi S; Besaratinia A; Wilczynski SP; Pfeifer GP
    Oncogene; 2011 Feb; 30(6):690-700. PubMed ID: 20890300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene.
    Purdie CA; Harrison DJ; Peter A; Dobbie L; White S; Howie SE; Salter DM; Bird CC; Wyllie AH; Hooper ML
    Oncogene; 1994 Feb; 9(2):603-9. PubMed ID: 8290271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.
    Venkatachalam S; Shi YP; Jones SN; Vogel H; Bradley A; Pinkel D; Donehower LA
    EMBO J; 1998 Aug; 17(16):4657-67. PubMed ID: 9707425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor spectrum in ARF-deficient mice.
    Kamijo T; Bodner S; van de Kamp E; Randle DH; Sherr CJ
    Cancer Res; 1999 May; 59(9):2217-22. PubMed ID: 10232611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53-deficient mouse: a model for basic and applied cancer studies.
    Donehower LA
    Semin Cancer Biol; 1996 Oct; 7(5):269-78. PubMed ID: 9110404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
    Sevignani C; Wlodarski P; Kirillova J; Mercer WE; Danielson KG; Iozzo RV; Calabretta B
    J Clin Invest; 1998 Apr; 101(8):1572-80. PubMed ID: 9541486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.